Home › Funds › Velan Capital Investment Management LP › NSRX
Velan Capital Investment Management LP position in NSRX
NASUS PHARMA LTD · Health Care
Velan Capital Investment Management LP reported holding 359,390 shares of NSRX (NASUS PHARMA LTD) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 1.27% of its reported portfolio and ranking #16 among its reported holdings. Velan Capital Investment Management LP has disclosed NSRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's NSRX position evolved
Velan Capital Investment Management LP first disclosed a stake in NSRX in Q1 2026 at 359,390 shares (US$798K). The position peaked in Q3 2026 at 359,390 shares, worth US$1.3M. Across 3 filings, Velan Capital Investment Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 359,390 shares valued at US$1.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 359.39K | $797.85K | New |
| Q2 2026 | 359.39K | $1.26M | Hold |
| Q3 2026 | 359.39K | $1.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NSRX and 13F data
NSRX (NASUS PHARMA LTD) is a Health Care company. 8 other funds we track also report a position in NSRX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held NSRX?
Velan Capital Investment Management LP has disclosed NSRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Velan Capital Investment Management LP's current position in NSRX?
As of Q3 2026, Velan Capital Investment Management LP holds 359.39K shares of NSRX (NASUS PHARMA LTD), valued at $1.33M, representing 1.27% of its reported portfolio and ranking #16.
Has Velan Capital Investment Management LP been buying or selling NSRX?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in NSRX. The position peaked in Q3 2026 at 359.39K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.